Distinct impact of imatinib on growth at prepubertal and pubertal ages of children with chronic myeloid leukemia

Journal of Pediatrics

Volumn 159, Issue 4, 2011, Pages 676-681

  Shima, Haruko ^a,b   Tokuyama, Mika ^c   Tanizawa, Akihiko ^d   Tono, Chikako ^e   Hamamoto, Kazuko ^f   Muramatsu, Hideki ^g   Watanabe, Akihiro ^h   Hotta, Noriko ⁱ   Ito, Masaki ^j   Kurosawa, Hidemitsu ^k   Kato, Koji ^l   Tsurusawa, Masahito ^m   Horibe, Keizo ⁿ   Shimada, Hiroyuki ^a  

^a KEIO UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

^d UNIVERSITY OF FUKUI   (Japan)

^e AOMORI ROSAI HOSPITAL   (Japan)

^f ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^g NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h NIIGATA CANCER CENTER HOSPITAL   (Japan)

ⁱ Tokuyama Central Hospital   (Japan)

^j FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^k DOKKYO MEDICAL UNIVERSITY   (Japan)

^l AICHI MEDICAL UNIVERSITY   (Japan)

^m JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

ⁿ NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

more..

Author keywords

Body surface area; BSA; Chronic myeloid leukemia; CML; GH; Growth hormone; PDGF; Platelet derived growth factor

Indexed keywords

HYDROXYUREA; IMATINIB;

ADOLESCENT; ARTICLE; BODY HEIGHT; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; GROWTH DISORDER; GROWTH RATE; HUMAN; JAPANESE; MALE; MEDICAL RECORD REVIEW; PREPUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBERTY; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ANTINEOPLASTIC AGENTS; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GROWTH DISORDERS; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; PIPERAZINES; PUBERTY; PYRIMIDINES; RETROSPECTIVE STUDIES;

EID: 80052790433     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2011.03.046     Document Type: Article

References (21)

1. M. Suttorp, and F. Millot Treatment of pediatric chronic myeloid leukemia in the year 2010: use of tyrosine kinase inhibitors and stem cell transplantation Hematology Am Soc Hematol Educ Progr 2010 368 376
2. S. Mariani, F. Giona, S. Basciani, M. Brama, and L. Gnessi Low bone density and decreased inhibin-B/FSH ratio in a boy treated with imatinib during puberty Lancet 372 2008 111 112 (Pubitemid 351958458)
3. T. Kimoto, M. Inoue, and K. Kawa Growth deceleration in a girl treated with imatinib Int J Hematol 89 2009 251 252
4. H. Schmid, B.A. Jaeger, J. Lohse, and M. Suttorp Longitudinal growth retardation in a prepubertal girl with chronic myeloid leukemia on long-term treatment with imatinib Haematologica 94 2009 1171 1179
5. F. Millot, A. Baruchel, J. Guilhot, A. Petit, T. Leblanc, and Y. Bertrandet Imatinib is efficient but has a negative impact on growth in children with previously untreated chronic myelogenous leukaemia (CML) in early chronic phase (CP): results of the French National Phase IV Trial (ASH annual meeting abstract) Blood 110 2009 863
6. M. Suttorp Innovative approaches of targeted therapy for CML of childhood in combination with paediatric haematopoietic SCT Bone Marrow Transplant 42 2008 S40 S46
7. R.D. Barr Imatinib mesylate in children and adolescents with cancer Pediatr Blood Cancer 55 2010 18 25
8. F. Millot, J. Guilhot, B. Nelken, T. Leblanc, E.S. De Bont, and A.N. Békassy Imatinib mesylate is effective in children with chronic myelogenous leukemia in late chronic and advanced phase and in relapse after stem cell transplantation Leukemia 20 2006 187 192 (Pubitemid 43148651)
9. M.A. Champagne, R. Capdeville, M. Krailo, W. Qu, B. Peng, and M. Rosamilia Imatinib mesylate (STI 571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study Blood 104 2004 2655 2660 (Pubitemid 39434944)
10. B.J. Druker Imatinib as a paradigm of targeted therapies Adv Cancer Res 91 2004 1 30 (Pubitemid 39140955)
11. S. Fitter, A.L. Dewar, P. Kostakis, L.B. To, T.P. Hughes, and M.M. Roberts Long-term imatinib therapy promotes bone formation in CML patients Blood 111 2008 2538 2547
12. E. Berman, M. Nicolaides, R.G. Maki, M. Fleisher, S. Chanel, and K. Scheu Altered bone and mineral metabolism in patients receiving imatinib mesylate N Engl J Med 354 2006 2006 2013
13. S. O'Sullivan, D. Naot, K. Callon, F. Porteous, A. Horne, and D. Wattie Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms J Bone Miner Res 22 2007 1679 1689 (Pubitemid 351235134)
14. I. El Hajj Dib, M. Gallet, R. Mentaverri, N. Sévenet, M. Brazier, and S. Kamel Imatinib mesylate (Gleevec) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity Eur J Pharmacol 551 2006 27 33 (Pubitemid 44648069)
15. K. Vandyke, S. Fitter, A.L. Dewar, T.P. Hughes, and A.C. Zannettino Dysregulation of bone remodelling by imatinib mesylate Blood 115 2010 766 774
16. A.L. Dewar, A.N. Farrugia, M.R. Condina, L. Bik To, T.P. Hughes, and B. Vernon-Roberts Imatinib as a potential antiresorptive therapy for bone disease Blood 107 2006 4334 4337 (Pubitemid 43801358)
17. W. Ando, J. Hashimoto, A. Nampei, H. Tsuboi, K. Tateishi, and T. Ono Imatinib mesylate inhibits osteoclastogenesis and joint destruction in rats with collagen-induced arthritis (CIA) J Bone Miner Metab 24 2006 274 282 (Pubitemid 43992670)
18. W.Y. Tse, P.C. Hindmarsh, and C.G. Brook The infancy-childhood-puberty model of growth: clinical aspects Acta Paediatr Scand Suppl 356 1989 38 43 (Pubitemid 19242165)
19. K. Vandyke, A.L. Dewar, S. Fitter, D. Menicanin, L.B. To, and T.P. Hughes Imatinib mesylate causes growth plate closure in vivo Leukemia 23 2009 2155 2159
20. M. Suttorp, J. Boehme, J. Vaitl, B. Mosch, S. Pursche, and R. Jung Side effects on the heart and skeleton of growing mice attributed to chronic imatinib exposure (ASH annual meeting abstract) Blood 112 2008 402
21. S.L. Hobernicht, B. Schweiger, P. Zeitler, M. Wang, and S.P. Hunger Acquired growth hormone deficiency in a girl with chronic myelogenous leukemia treated with tyrosine kinase inhibitor therapy Pediatr Blood Cancer 56 2011 671 673